Coronavirus super-spreader events all have notable similarities — and they reveal the types of gatherings we should avoid for years
...Research shows time and again that the risk of coronavirus spread is much higher indoors, in poorly ventilated spaces in which lots of people have sustained contact. That’s because it primarily spreads via droplets that fly through the air when an infected person coughs, sneezes, or speaks.
A preliminary report from Japanese scientists (which has yet to be peer-reviewed) suggested that the odds an infected person “transmitted COVID-19 in a closed environment was 18.7 times greater compared to an open-air environment.”
INOVIO TRIAL ANNOUNCED - DNA Plasmids
Inovio has enrolled 40 healthy volunteers in its phase 1 trial and expects preliminary data on safety and immune response in late June. Participants are receiving two doses of vaccine, four weeks apart. If results are favorable, the company plans to move on to a phase 2/3 efficacy trial this summer upon regulatory approval.
MODERNA ENTERS PHASE 2 TRIALS - RNA Transcription
Moderna’s phase 2 study will include 600 participants in two groups according to age — 18 to 55 and 55 and older. Subjects may receive placebo, or one of two different doses of the vaccine.
there are currently over 70 vaccine trails in process. Both Innovio and Moderna anticipate entering phase 3 trials this summer.
It also reveals the attendees stupid rating.
Once again, the example in little rural Mason Co., TX that had zero confirmed cases until the Mayor decided he was above the stay home ruling and went on vacation to the beach. He infected 27 people all from one city council meeting.